Amphastar Pharmaceuticals, Inc...
NasdaqGS:AMPH
$ 42.43
+ $0.22 (0.52%)
$ 42.43
+ $0.22 (0.52%)
End-of-day quote: 05/09/2024

Amphastar Pharmaceuticals financials at a glance

The revenue of Amphastar Pharmaceuticals is reported as 0.6444 billion Dollars in the fiscal year 2023. The earnings were 3.32 Dollars per share in 2023, which was 68.53 higher than 2022. And about 0.14533 billion Dollars are reported as free cash flow in the financials of Amphastar Pharmaceuticals 2023. No dividends were paid to the shareholders of the Amphastar Pharmaceuticals stock NasdaqGS:AMPH in the financial year 2023.

$644.40M
Revenue
$3.32
Earnings Per Share
54.91%
Gross Margin %
$0.00M
Free Cash Flow
Revenue
644.40
Earnings Per Share
3.32
Gross Margin %
54.91
Free Cash Flow
0.00

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Rev. Revenue N/A $644.40M $498.99M $437.77M $349.85M $322.36M $294.67M $240.18M $255.17M $251.52M $210.46M
GM % Gross Margin % 54.69% 54.91% 49.87% 45.63% 40.97% 40.92% 36.31% 37.68% 40.83% 30.75% 24.35%
OM Operating Margin 30.52% 30.99% 21.54% 16.38% 3.79% -0.01% -2.93% -1.63% 6.18% -1.43% -8.54%
EPS Earnings Per Share $2.56 $3.32 $1.97 $1.37 $0.64 $0.36 $0.21 $0.38 $0.49 $0.06 $-0.12
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0.00% 0 0 0 0 0 0 0 0 0
Sha. Shares N/AM 48.1M 47.9M 48.15M 47.43M 46.24M 46.79M 46.35M 45.91M 44.91M 44.56M
OCF Operating Cash Flow N/A $183.50M $89.18M $97.99M $57.27M $41.76M $38.19M $39.21M $38.56M $10.68M $21.10M
FCF Free Cash Flow N/A $145.33M $65.15M $70.53M $23.41M $0.21M $-8.62M $4.11M $17.18M $-5.37M $0.60M
FCFS Free Cash Flow Per Share $2.89 $3.01 $1.34 $1.48 $0.50 $0.00 $-0.09 $0.13 $0.38 $-0.12 $0.01